Resistentia Pharmaceuticals AB
Records under this name other than patents Resistentia Pharmaceuticals AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Resistentia Pharmaceuticals AB
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,913,749 | Immunogenic polypeptides for inducing anti-self IgE responses Formerly held Lapsed on the fee record Ended Jul 5, 2013 · From the USPTO record | Lapsed on the fee record | Ended Jul 5, 2013 | From the USPTO record |
| US 7,459,158 | Immunogenic polypeptides for inducing anti-self IgE responses Formerly held Lapsed on the fee record Ended Dec 2, 2012 · From the USPTO record | Lapsed on the fee record | Ended Dec 2, 2012 | From the USPTO record |
| US 7,361,742 | Methods and materials for treating inflammatory conditions Formerly held Lapsed on the fee record Ended Apr 22, 2012 · From the USPTO record | Lapsed on the fee record | Ended Apr 22, 2012 | From the USPTO record |
| US 7,232,898 | Chimeric IgE polypeptides and host cells Formerly held Lapsed on the fee record Ended Jun 19, 2011 · From the USPTO record | Lapsed on the fee record | Ended Jun 19, 2011 | From the USPTO record |
| US 5,653,980 | Vaccine comprising part of constant region of IgE for treatment of IgE-mediated allergic reactions Formerly held Term ended Term ended no later than Aug 5, 2017 · Low confidence | Term ended | Term ended no later than Aug 5, 2017 | Low confidence |